Globus Medical Inc (GMED)

$89.00 +0.91 (1.03%)
Market Cap 11.79B
Revenue (ttm) 2.52B
Net Income (ttm) 102.98M
EPS (ttm) N/A
PE Ratio 24.50
Forward PE 21.12
Profit Margin 4.09%
Debt to Equity Ratio 0.00
Volume 782,778
Avg Vol 1,369,326
Day's Range N/A - N/A
Shares Out 133.84M
Stochastic %K 66%
Beta 1.06
Analysts Strong Sell
Price Target $105.85

Company Profile

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers musculoskeletal solutions, including spine products, such as traditional fusion implants, and treatment options for motion preservation technologies, and interventional solutions to treat vertebral compression fractures; orthopedic trauma solutions, which includes fracture plating, intramedullary...

Industry: Medical Devices
Sector: Healthcare
Phone: 610 930 1800
Address:
2560 General Armistead Avenue, Audubon, United States
SuperGreenToday
SuperGreenToday Feb. 5 at 6:54 PM
$GMED Share Price: $87.33 Contract Selected: Sep 18, 2026 $87.5 Calls Buy Zone: $9.78 – $12.08 Target Zone: $16.33 – $19.95 Potential Upside: 58% ROI Time to Expiration: 224 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Leondog1992
Leondog1992 Jan. 29 at 7:04 PM
$FROG $GH $GMED $IRTC $RKT Just remember money and this life is only Temporary. Jesus is king
1 · Reply
Leondog1992
Leondog1992 Jan. 29 at 4:43 PM
$FROG $RKT $GH $IRTC $GMED
1 · Reply
ANGRYmedINVESTOR
ANGRYmedINVESTOR Jan. 27 at 6:56 PM
$GMED THE ONLY SPINE CO THAT MAKES MONEY
0 · Reply
rottieluvr3
rottieluvr3 Jan. 16 at 8:55 PM
$GMED Dumped this earlier when it was +.70%. Took my profits and ran. 💴💲💰
0 · Reply
Albino_Trader123
Albino_Trader123 Jan. 15 at 5:01 PM
$GMED Not an exciting name. But good for investors. They have the moat like $ISRG Rev and EPS healthy growth.
0 · Reply
IN0V8
IN0V8 Jan. 8 at 4:58 PM
$GMED Buy Barclays raises target price to $118 from $114 Jefferies raises target price to $115 from $105 RBC raises target price to $115 from $100
0 · Reply
Arcides
Arcides Jan. 8 at 4:55 PM
$GMED not what you wanna see after good news
0 · Reply
FlUmPo_41TwErN
FlUmPo_41TwErN Jan. 8 at 2:36 PM
$GMED Santa Clara is pure pain: two 50MW sites ready, but ~$450M grid upgrades won’t finish until 2028+… like come on. In an AI land grab, that’s years of dead carry. Behind-the-meter microgrids turn “nice building” into “live compute” while utilities crawl. That’s the whole edge right there 🔥
0 · Reply
MaverikIT
MaverikIT Jan. 8 at 2:29 PM
$GMED nice
0 · Reply
Latest News on GMED
Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

Feb 12, 2026, 4:30 PM EST - 5 days ago

Globus Medical Schedules Fourth Quarter and Full Year 2025 Earnings Release and Conference Call

Steven Cress' Top 10 AI Stocks (Recap & Update)

Feb 4, 2026, 6:50 PM EST - 13 days ago

Steven Cress' Top 10 AI Stocks (Recap & Update)

AIQ APP CIEN CLS CRDO GM HUT

Top 10 AI Stocks For 2026

Jan 20, 2026, 5:00 AM EST - 4 weeks ago

Top 10 AI Stocks For 2026

APP CIEN CLS CRDO GM HUT LITE

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Jan 7, 2026, 4:27 PM EST - 5 weeks ago

Globus Medical Reports Preliminary Record Fourth Quarter and Full Year Sales Results

Globus Medical: Straightening Its Back

Nov 11, 2025, 10:00 AM EST - 3 months ago

Globus Medical: Straightening Its Back

Globus Medical Stock Soars After Earnings. Where It's Seeing the Strength.

Nov 7, 2025, 11:08 AM EST - 3 months ago

Globus Medical Stock Soars After Earnings. Where It's Seeing the Strength.

Globus Medical, Inc. (GMED) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 9:56 PM EST - 3 months ago

Globus Medical, Inc. (GMED) Q3 2025 Earnings Call Transcript

Globus Medical Reports Third Quarter 2025 Results

Nov 6, 2025, 4:15 PM EST - 3 months ago

Globus Medical Reports Third Quarter 2025 Results

Is Wall Street Underestimating Globus Medical Stock's Potential?

Oct 22, 2025, 11:25 AM EDT - 4 months ago

Is Wall Street Underestimating Globus Medical Stock's Potential?

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

Oct 16, 2025, 4:30 PM EDT - 4 months ago

Globus Medical Schedules Third Quarter Earnings Release and Conference Call

Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma

Oct 14, 2025, 4:40 PM EDT - 4 months ago

Globus Medical Launches ANTHEM™ Elbow Fracture System: A Comprehensive Plating Portfolio for Complex Elbow Trauma

Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.

Aug 28, 2025, 4:30 PM EDT - 6 months ago

Globus Medical, Inc. Secures Jury Verdict in Delaware Patent Litigation Against Life Spine, Inc.

Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript

Aug 8, 2025, 3:05 PM EDT - 6 months ago

Globus Medical, Inc. (GMED) Q2 2025 Earnings Call Transcript

Globus Medical Reports Second Quarter 2025 Results

Aug 7, 2025, 4:15 PM EDT - 6 months ago

Globus Medical Reports Second Quarter 2025 Results

Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results

Jul 21, 2025, 8:00 AM EDT - 7 months ago

Globus Medical Announces Leadership Transitions and Preliminary Second Quarter 2025 Sales Results

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

Jul 17, 2025, 4:30 PM EDT - 7 months ago

Globus Medical Schedules Second Quarter Earnings Release and Conference Call

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

Jul 15, 2025, 4:15 PM EDT - 7 months ago

Globus Medical Introduces DuraPro™ with Navigation, a Next-Generation, Oscillating System Designed to Safeguard Delicate Tissue

Globus Medical: Obtaining My Backing Again

Jul 3, 2025, 12:10 PM EDT - 8 months ago

Globus Medical: Obtaining My Backing Again

Globus Medical Announces $500 Million Share Repurchase Program

May 15, 2025, 4:30 PM EDT - 9 months ago

Globus Medical Announces $500 Million Share Repurchase Program

Medical, Inc. Company Investigated by the Portnoy Law Firm

May 13, 2025, 6:28 PM EDT - 10 months ago

Medical, Inc. Company Investigated by the Portnoy Law Firm

Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript

May 8, 2025, 10:32 PM EDT - 10 months ago

Globus Medical, Inc. (GMED) Q1 2025 Earnings Call Transcript

Globus Medical Reports First Quarter 2025 Results

May 8, 2025, 4:15 PM EDT - 10 months ago

Globus Medical Reports First Quarter 2025 Results

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Apr 17, 2025, 4:30 PM EDT - 10 months ago

Globus Medical Schedules First Quarter Earnings Release and Conference Call

Globus Medical completes acquisition of Nevro Corp.

Apr 3, 2025, 8:31 AM EDT - 11 months ago

Globus Medical completes acquisition of Nevro Corp.

NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO

Mar 21, 2025, 11:30 AM EDT - 11 months ago

NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO

NVRO

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Mar 11, 2025, 4:40 PM EDT - 1 year ago

Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Mar 6, 2025, 4:40 PM EST - 1 year ago

Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Mar 5, 2025, 7:01 PM EST - 1 year ago

Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

Mar 4, 2025, 4:15 PM EST - 1 year ago

Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results

NVRO

Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 9:54 PM EST - 1 year ago

Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

Feb 20, 2025, 4:15 PM EST - 1 year ago

Globus Medical Reports Fourth Quarter and Full Year 2024 Results

SuperGreenToday
SuperGreenToday Feb. 5 at 6:54 PM
$GMED Share Price: $87.33 Contract Selected: Sep 18, 2026 $87.5 Calls Buy Zone: $9.78 – $12.08 Target Zone: $16.33 – $19.95 Potential Upside: 58% ROI Time to Expiration: 224 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
Leondog1992
Leondog1992 Jan. 29 at 7:04 PM
$FROG $GH $GMED $IRTC $RKT Just remember money and this life is only Temporary. Jesus is king
1 · Reply
Leondog1992
Leondog1992 Jan. 29 at 4:43 PM
$FROG $RKT $GH $IRTC $GMED
1 · Reply
ANGRYmedINVESTOR
ANGRYmedINVESTOR Jan. 27 at 6:56 PM
$GMED THE ONLY SPINE CO THAT MAKES MONEY
0 · Reply
rottieluvr3
rottieluvr3 Jan. 16 at 8:55 PM
$GMED Dumped this earlier when it was +.70%. Took my profits and ran. 💴💲💰
0 · Reply
Albino_Trader123
Albino_Trader123 Jan. 15 at 5:01 PM
$GMED Not an exciting name. But good for investors. They have the moat like $ISRG Rev and EPS healthy growth.
0 · Reply
IN0V8
IN0V8 Jan. 8 at 4:58 PM
$GMED Buy Barclays raises target price to $118 from $114 Jefferies raises target price to $115 from $105 RBC raises target price to $115 from $100
0 · Reply
Arcides
Arcides Jan. 8 at 4:55 PM
$GMED not what you wanna see after good news
0 · Reply
FlUmPo_41TwErN
FlUmPo_41TwErN Jan. 8 at 2:36 PM
$GMED Santa Clara is pure pain: two 50MW sites ready, but ~$450M grid upgrades won’t finish until 2028+… like come on. In an AI land grab, that’s years of dead carry. Behind-the-meter microgrids turn “nice building” into “live compute” while utilities crawl. That’s the whole edge right there 🔥
0 · Reply
MaverikIT
MaverikIT Jan. 8 at 2:29 PM
$GMED nice
0 · Reply
OpenOutcrier
OpenOutcrier Jan. 8 at 1:49 PM
$GMED (+8.1% pre) Globus Medical Shares Up After Preliminary 4Q Results, 2026 Outlook Beat Forecasts https://ooc.bz/l/89050
0 · Reply
Avj7
Avj7 Jan. 8 at 1:35 PM
$GMED Only 1586 watchers here? Lots of Stocktwitters missing out on a great company🤷‍♀️
0 · Reply
notreload_ai
notreload_ai Jan. 8 at 11:34 AM
$GMED shares jump in premarket trading after reporting preliminary Q4 sales of $823.2M, beating analyst estimates, with strong 2026 guidance signaling continued growth momentum. https://notreload.xyz/globus-medical-stock-jumps-on-strong-q4-sales-outlook/
0 · Reply
DonCorleone77
DonCorleone77 Jan. 8 at 3:58 AM
$GMED $AVAV $LMT $IMRX $PHAT AFTER HOURS MOVERS: Currently Higher After Earnings: - Constellation Brands (STZ) up 1.7% Currently Also Higher: - Globus Medical (GMED) up 9.3% after providing guidance for Q4, FY25, and FY26 - Gap (GAP) up 3.9 after UBS upgraded the stock to Buy from Neutral - Sanara MedTech (SMTI) up 2.0% after receiving a Biasurge contract from Vizient Currently Higher After Trump Comments on Military Budget: - AeroVironment (AVAV) up 7.2% - Lockheed Martin (LMT) up 6.3% - Northrop Grumman (NOC) up 5.7% - L3Harris (LHX) up 5.1% - General Dynamics (GD) up 4.2% - Huntington Ingalls (HII) up 3.2% - RTX Corp. (RTX) up 3.2% Currently Lower After Earnings: - Resources Connection (RGP) down 10.8% - Franklin Covey (FC) down 10.2% - Jefferies Financial (JEF) down 3.0% Currently Also Lower: - Immuneering (IMRX) down 20.7% after reporting overall survival and safety data from its atebimetinib trial - Phathom Pharmaceuticals (PHAT) down 11.7% after announcing a common stock offering and raising its FY25 revenue guidance
0 · Reply
RazorbackAJ
RazorbackAJ Jan. 7 at 9:59 PM
$GMED Great earnings - going long with current trailing stop at $92.
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Dec. 24 at 9:03 PM
$GMED RSI: 49.02, MACD: 2.1973 Vol: 1.70, MA20: 88.36, MA50: 78.34 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
LiveTradePro
LiveTradePro Dec. 22 at 7:12 PM
$GMED https://share.trendspider.com/chart/GMED/6682hj8ngw
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 8:34 PM
RBC Capital updates rating for Globus Medical ( $GMED ) to Outperform, target set at 101 → 95.
0 · Reply
JarvisFlow
JarvisFlow Dec. 19 at 8:33 PM
RBC Capital updates rating for Globus Medical ( $GMED ) to Outperform, target set at 95 → 88.
0 · Reply
ARMRreport
ARMRreport Dec. 19 at 7:23 PM
Hot off the press... The 2026 Medical Robotics Landscape: Industrialization & Integration #StocksToWatch $ISRG $GMED $RXRX $TEM $PRCT https://armrinvesting.substack.com/publish/post/182114397?utm_campaign=post-expanded-share&utm_medium=web #investing
0 · Reply
LiveTradePro
LiveTradePro Dec. 18 at 9:50 PM
$GMED Bull flag setup, confirmed https://share.trendspider.com/chart/GMED/6682bz3gku
0 · Reply
ZacksResearch
ZacksResearch Dec. 18 at 2:11 PM
These MedTech names ran hard — but 2026 could be a reality check. ⚠️ Some skyrocketed MedTech stocks like $GMED, $TMDX, and $HIMS may see momentum slow heading into 2026. See which risks could trip them up 👉 https://www.zacks.com/stock/news/2806066/3-skyrocketing-medtech-stocks-that-might-lose-steam-in-2026?cid=sm-stocktwits-2-2806066-teaser-25356&ADID=SYND_STOCKTWITS_TWEET_2_2806066_TEASER_25356
0 · Reply